LAKEWOOD, Colo., Nov. 10 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. today announced that its Board of Directors has declared a regular quarterly cash dividend of 10 cents per share of common stock, payable on December 15, 2008 to shareholders of record at the close of business on November 26, 2008.
Since establishing the regular quarterly dividend in November of 2003, the Board has maintained a policy of reviewing the Company’s dividend annually at its regular November meeting. While the Board believes that the Company has the capacity to raise the dividend at this time, they have chosen to maintain the dividend at the current rate and exercise caution with the Company’s cash assets given the current disruptions in the credit markets and the Company’s desire to further its growth through acquisitions which may utilize a large portion of those assets in the future.
Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.
This news release contains forward-looking statements which involve risks and uncertainties. The Company’s actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company’s Annual Report on Form-10K for the year ended March 31, 2008 as filed with the Securities and Exchange Commission, and from time to time in the Company’s other reports on file with the Commission.
CONTACT: Luke R. Schmieder, CEO-Chairman of the Board of Directors, or
John J. Sullivan, President-COO, or Steven W. Peterson, VP Finance-CFO, all
of Mesa Laboratories, Inc., +1-303-987-8000
Web site: http://www.mesalabs.com/
